Molecules/IPILIMUMAB

IPILIMUMAB

Molecular Identity

AntibodyApprovedFirst approved 2011

Mechanism of action: Cytotoxic T-lymphocyte protein 4 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

BMS-734016BMS734016IPILIMUMABMDX-010MDX010MDX-010 MDX-CTLA4MDX-101MDX-CTLA-4YERVOY

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to IPILIMUMAB

Loading drug network...